相关实验视频
Updated: Jan 28, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
活体人类结肠爆炸物在性结肠炎中识别了代谢变化和细胞因子失调:试点研究
Cathy McShane1, Fiona O'Connell2, David Kevans3
1Department of Gastroenterology, St. James's Hospital Dublin and School of Medicine, Trinity College Dublin, Dublin, Ireland. mcshanca@tcd.ie.
性结肠炎 (UC) 显示线粒体功能受损和糖分分解增加,随着疾病持续时间的加剧而恶化. 与健康对照组相比,刺激性肠综合征 (IBS) 患者没有显著的代谢差异.
科学领域:
- 胃肠病学 胃肠病学
- 细胞的新陈代谢
- 免疫学 免疫学 免疫学
背景情况:
- 线粒体功能障碍与性结肠炎 (UC) 有关,但关于粘膜体生物能和炎症的人类数据很少.
- 对刺激性肠综合征 (IBS) 的代谢贡献尚不清楚.
研究的目的:
- 在健康对照组 (HC),IBS,缓解UC和活跃UC中特征化ex vivo结肠代谢和炎症概况.
- 评估这些特征与疾病持续时间等临床因素之间的关联.
主要方法:
- 海马分析西格体活检以测量氧化酸化 (OCR) 和糖解 (ECAR).
- 探索条件介质的细胞因子分析.
- 统计比较,主要组件分析和回归建模.
主要成果:
- 与HC相比,UC患者 (缓解和活跃) 的OCR和OCR:ECAR比率明显较低.
- 活性UC显示IL-4,IL-6,IFN-γ和IL-1β的增加.
- 增加的ECAR与更长的UC疾病持续时间相关;IBS没有显示与HC的代谢或细胞因子差异.
结论:
- 性结肠炎的特征是氧化酸化受损和糖分解增加,细胞因子分泌量增加.
- 渐进的粘膜代谢变化是慢性UC的特征.
- 在IBS中的代谢概况与健康个体没有显著差异.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Pilot and Numeric Relaying
The Colonization of Land
What is Metabolism?
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.